Aim High Investment Group LLC v. Spectrum Laboratories, LLC

District Court, D. Nevada·Decided February 14, 2024·No. 2:22-cv-00158·Unknown

Opinion

1 UNITED STATES DISTRICT COURT

2 DISTRICT OF NEVADA 3

4 AIM HIGH INVESTMENT GROUP, LLC, ) ) Case No.: 2:22-cv-00158-GMN-DJA 5 Plaintiff, ) 6 vs. ) ) 7 SPECTRUM LABORATORIES, LLC, ) ORDER DENYING ) AIM HIGH’S OBJECTION 8 Defendant. ) ) 9 ) 10 SPECTRUM LABORATORIES, LLC, ) ) 11 Counter-Claimant, ) vs. ) 12 ) 13 AIM HIGH INVESTMENT GROUP, LLC, ) ) 14 Counter-Defendant. ) ) 15 16 Pending before the Court is Plaintiff and Counter-Defendant Aim High Investment 17 Group’s (“Aim High’s”) Objection/Appeal, (ECF No. 91), to the Magistrate Judge’s Orders, 18 (ECF Nos. 86, 89), denying Aim High’s Motion to Compel Discovery (ECF No. 45). 19 Defendant and Counter-Claimant Spectrum Laboratories (“Spectrum”) filed a Response, (ECF 20 No. 94), to the Objection. 21 Because Aim High fails to establish that the Magistrate Judge’s Order was clearly 22 erroneous or contrary to law, the Court DENIES Aim High’s Objection.1 23 /// 24

25 1 ECF No. 86 is the Magistrate Judge’s sealed order, and ECF No. 89 is the redacted version. For simplicity, this Order will refer to them as one order, in the singular. 1 I. BACKGROUND 2 This action arises from a patent infringement dispute based on Spectrum’s patented 3 synthetic urine formulas. (See generally Compl., ECF No. 1). The patents center on a formula 4 containing biocides added to minimize bacteria growth in the mixture, thus preserving the shelf 5 life of the synthetic urine. (Id. ¶ 2). Before litigation began, Spectrum sent a letter to Aim High 6 alleging that the XStream product infringed two of its Patents. (Id. ¶ 11). In response, Aim 7 High denied the allegation and requested lab tests demonstrating infringement. 8 (Correspondence, Exs. A-C to Resp. to Mot. Compel, ECF Nos. 51-1, 51-2, 51-3). Spectrum 9 provided a redacted report from S&N Laboratories, stating that the report was disclosed 10 “without any waiver of privilege or work-product.” (Confidential Letter, Ex. D to Resp. Mot. 11 Compel, ECF No. 51-4). Aim High challenged the authenticity of the report, so Spectrum sent 12 Aim High a report from a second lab, Element Laboratories. (Letter and Element Report, Ex. 2 13 to Mot Compel, ECF No. 45-3). Aim High reviewed the correspondence and lab reports, and 14 then brought a claim for declaratory judgment that its XStream product does not infringe on 15 Spectrum’s patents. (Compl. ¶ 1). Spectrum counter-claimed for injunctive relief and damages, 16 alleging that the XStream product did infringe. (Counterclaim, ECF No. 7). 17 A. Related Litigation in California 18 In the United States District Court for the Central District of California, Aim High 19 issued subpoenas to S&N and Element. (Subpoenas, Exs. 9-10 to Resp. to Mot. Compel, ECF 20 No. 51-9, 51-10). The subpoenas requested undisclosed documents and communications 21 relating to any chemical testing of XStream or testing of third-party products done for the 22 purpose of detecting a biocide. (Id.). Both labs objected on work-product grounds as to 23 XStream, and work-product and irrelevance as to the third-party products. (Opp. to CA Mot. 24 Compel, Ex. 10 to Mot. Compel, ECF No. 45-11).

25 /// 1 Aim High moved to compel the documents. (CA Mot. Compel, Ex. 9 to Mot. Compel, 2 ECF No. 45-10). Aim High’s Motion argued the labs should be ordered to comply with the 3 subpoenas because Spectrum produced the reports in pre-litigation correspondence and 4 “expressly referenced the Element lab report as a document Spectrum was relying on to support 5 its claims.” (Id. 3:11–19). Aim High also pointed out that Spectrum listed the Element report in 6 its initial disclosures. (Id. 5:17–18). 7 Spectrum, S&N, and Element opposed the motion to compel because (1) an expert does 8 not waive work-product for undisclosed documents unless and until they are designated as the 9 testifying expert and produce a report, and (2) the testing of third-parties was irrelevant. (Resp. 10 at 4, ECF No. 94) (Opp. to CA Mot. Compel at 4–5, Ex. 10 to Mot. Compel). The California 11 Magistrate Judge ruled in Spectrum’s favor. (See generally Order, Ex. 12 to Mot. Compel, ECF 12 No. 45-13). The Magistrate Judge determined that Federal Rule of Civil Procedure 13 26(b)(4)(D), which prohibits a party from discovering facts known or opinions held by a non- 14 testifying expert retained in anticipation of litigation or preparation for trial, protected the labs 15 from compliance with Aim High’s subpoena. (Id. at 5–6). The protection was not waived 16 simply because Spectrum provided the reports to Aim High during pre-litigation discussions. 17 (Id.). 18 Aim High objected to the portion of the California Judge’s Denial of compelled 19 responses relating to Element’s testing of XStream. (CA Obj. at 2, Ex. 13 to Mot. Compel, ECF 20 No 45-14). Aim High argued that Spectrum’s citing of the Element test in its counterclaim 21 constituted a waiver of the work-product privilege and that the Magistrate Judge overlooked 22 Spectrum’s initial disclosures and counterclaim citations to Element’s lab test. (Id. at 2, 8). As 23 of the date of this Order, the District Judge in the Central District of California has not yet ruled 24 on Aim High’s objection.

25 /// 1 B. Magistrate Judge Albregts’ Denial of Aim High’s Motion to Compel 2 Aim High then filed another motion to compel Spectrum to respond to Aim High’s 3 Interrogatories Nos. 2–6 and Requests for Production Nos. 2–6 in this case. (Mot. Compel at 2, 4 ECF No. 45). Magistrate Judge Albregts determined that Aim High’s questions sought 5 “information like that which Aim High sought from Element and S&N.” (MJ Order 5:1–6:1, 6 ECF No. 89). In its NV Motion to Compel, Aim High made many similar arguments, such as 7 that Spectrum waived the work-product privilege by citing the Element lab test in its 8 counterclaim, and that Spectrum provided false information to the California Magistrate Judge 9 by stating that it only used the reports for settlement discussions and not to prove infringement. 10 (Id. 6:5–12). 11 Magistrate Judge Albregts denied Aim High’s Motion to Compel as “premature” 12 because of Aim High’s pending objection before the United States District Court for the 13 Central District of California, citing R.R. Street & Co. Inc. v. Transport Ins. Co., 656 F.3d 966 14 (9th Cir. 2011). (Id. 2:1–4). In R.R. Street, the Ninth Circuit explained that “courts usually 15 avoid duplicative litigation when similar cases are pending in two different federal courts,” and 16 that “[p]iecemeal litigation occurs when different tribunals consider the same issue, thereby 17 duplicating efforts and possibly reaching different results.” 656 F.3d at 974–75, 979. 18 The Magistrate Judge explained, because Aim High’s discovery requests to Spectrum 19 raise similar issues to the issues currently before the California District Court, the California 20 decision would “alter the scope of Aim High’s requests.” (MJ Order 2:14). He also noted that 21 Aim High made the same arguments in its NV Motion to Compel that it made in its objections 22 to the California Magistrate Judge’s Order. (Id. 7:11–15). “And if this Court were to find that 23 Spectrum must respond to Aim High’s discovery requests, but the California court were to find 24 that S&N and Element need not provide that same information, it could create a problematic

25 contradiction.” (Id. 7:12–15). Aim High now appeals this Order. (Obj., ECF No. 91). 1 II. LEGAL STANDARD 2 When reviewing the order of a magistrate judge, the order should be set aside only if the 3 order is clearly erroneous or contrary to law. Fed. R. Civ. P. 72(a); LR IB 3-1(a); 28 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Aim High Investment Group LLC v. Spectrum Laboratories, LLC, (D. Nev. 2024).

Aim High Investment Group LLC v. Spectrum Laboratories, LLC (Aim High Investment Group LLC v. Spectrum Laboratories, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related